Consensus Athira Pharma, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2024 am IST			5-day change	1st Jan Change
2.18 ^USD	+10.66%		+10.66%	-10.29%

15/04	Athira Pharma, Inc. Appoints Javier San Martin, M.D., as Chief Medical Officer	CI
11/04	Athira Pharma, Inc. Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease	CI

13.IWpojs_8S04yPTbtC6n3lVolP0uPw_UFoQRVizAbRfA.YAUv4oPPKDRTDVvdeeax0g9cZi64mcBExzZluH1IE8V-JVr-ua8ULAdnZw~d8374402d77e120bb179882a4ec986a4

JMP Securities Adjusts Athira Pharma Price Target to $19 From $20, Maintains Market Outperform Rating	11/23/11	MT
Mizuho Cuts Price Target on Athira Pharma to $5 From $6, Reiterates Buy Rating	15/23/15	MT
BTIG Adjusts Price Target on Athira Pharma to $10 From $33, Maintains Buy Rating	30/23/30	MT
JMP Securities Upgrades Athira Pharma to Market Outperform From Market Perform; Price Target is $20	18/22/18	MT
Mizuho Securities Initiates Athira Pharma at Buy with $6 Price Target	07/22/07	MT
Mizuho Initiates Athira Pharma With Buy Rating, $6 Price Target, Potentially 'Mis-Priced' Stock	07/22/07	MT
Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors	01/22/01	MT
Goldman Sachs Adjusts Price Target for Athira Pharma to $3 From $11, Maintains Neutral Rating	23/22/23	MT
Stifel Nicolaus Downgrades Athira Pharma to Hold From Buy, Adjusts Price Target to $5 From $36	23/22/23	MT
JMP Securities Downgrades Athira Pharma to Market Perform From Market Outperform	23/22/23	MT
Jefferies Downgrades Athira Pharma to Hold From Buy, Adjusts Price Target to $3 From $32	23/22/23	MT
BTIG Starts Athira Pharma at Buy With $33 Price Target	10/22/10	MT
Berenberg Bank Initiates Coverage on Athira Pharma With Buy Rating, $33 Price Target	21/22/21	MT
Goldman Sachs Reinstates Athira Pharma at Neutral With $16 Price Target	15/21/15	MT

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.18 USD

Average target price

7.417 USD

Spread / Average Target

+240.21%

High Price Target

19 USD

Spread / Highest target

+771.56%

Low Price Target

3 USD

Spread / Lowest Target

+37.61%